Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment
Background The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathologic...
Saved in:
Published in | International journal of clinical oncology Vol. 20; no. 6; pp. 1161 - 1170 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
Springer Japan
01.12.2015
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control.
Methods
We collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors.
Results
The 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (
P
= 0.043) but was not an independent prognostic factor in the multivariate analysis (
P
= 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS.
Conclusions
This study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy. |
---|---|
AbstractList | Background
The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control.
Methods
We collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors.
Results
The 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (
P
= 0.043) but was not an independent prognostic factor in the multivariate analysis (
P
= 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS.
Conclusions
This study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy. BACKGROUNDThe purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control.METHODSWe collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors.RESULTSThe 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (P = 0.043) but was not an independent prognostic factor in the multivariate analysis (P = 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS.CONCLUSIONSThis study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy. The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control. We collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors. The 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (P = 0.043) but was not an independent prognostic factor in the multivariate analysis (P = 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS. This study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy. Background: The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on survival of such clinical and pathological factors such as histological subtype (HS) and nuclear grade by conducting a central pathological review based on the current World Health Organization classification and the staging system of the American Joint Committee on Cancer/Union for International Cancer Control. Methods: We collected glass slides and clinical data sets for 914 cases of RCC treated with curative nephrectomy from 1995 to 2000. Overall (OS), cancer-specific (CSS), and relapse-free (RFS) survival were compared for HS and nuclear grades determined by a central pathology review board comprising 5 board-certified pathologists, pathological staging, and a variety of clinical factors. Results: The 5 and 7-year CSS in this study were 96 and 93 %, respectively, values superior to those reported in Western countries. Concordance between the original and reviewed HS and nuclear grades were 90.9 and 21.1 %, respectively. HS correlated with OS (P = 0.043) but was not an independent prognostic factor in the multivariate analysis (P = 0.820). Tumor size, Fuhrman grade, and infiltration type were common independent prognostic factors for OS, CSS, and RFS. Conclusions: This study revealed RCC outcomes in the era of cytokine treatment for metastasis. Central pathological review is an essential component of a multicenter study with long-term follow-up. Tumor size, Fuhrman grade, and infiltration type had much greater effects than HS on survival after curative nephrectomy. |
Author | Ito, Noriyuki Teramukai, Satoshi Ogawa, Osamu Kojima, Shinsuke Kamba, Tomomi Mikami, Yoshiki |
Author_xml | – sequence: 1 givenname: Noriyuki surname: Ito fullname: Ito, Noriyuki email: nito@kuhp.kyoto-u.ac.jp organization: Department of Urology, Nishi-Kobe Medical Center – sequence: 2 givenname: Shinsuke surname: Kojima fullname: Kojima, Shinsuke organization: Translational Research Informatics Center, Foundation for Biomedical Research and Innovation – sequence: 3 givenname: Satoshi surname: Teramukai fullname: Teramukai, Satoshi organization: Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine – sequence: 4 givenname: Yoshiki surname: Mikami fullname: Mikami, Yoshiki organization: Department of Diagnostic Pathology, Kumamoto University Hospital – sequence: 5 givenname: Osamu surname: Ogawa fullname: Ogawa, Osamu organization: Department of Urology, Graduate School of Medicine, Kyoto University – sequence: 6 givenname: Tomomi surname: Kamba fullname: Kamba, Tomomi organization: Department of Urology, Graduate School of Medicine, Kyoto University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25981949$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkctu1TAQhi1URG88ABtkiU03AV_jZIkqKEiVumnXluOMz3E5sYPttDpvwuPicApCSEjdjD2ab_7RzH-KjkIMgNAbSt5TQtSHTAkVqiFUNqQTpJEv0AkVXDVKKXZU_1zQpm-ZPEanOd8TQlUr2St0zGTf0V70J-jHzVJsnCDj6LBdkin-AXCAeZvAljjtsdkYH3LBCYLZYQu7GkyyPsTJ4MFkGHEM2NRKKKkSsynbuIsbb2uS4MHD46rdU4HzDNZPEDJ2KU64bAFDMr8m70v85gPgksCUipRz9NKZXYbXT-8Zuvv86fbyS3N9c_X18uN1Y-sqpeEORmmt7MSonGNOGkcYd1wNPe9qJFbI0UlJx2GQvGWmd7LebGBm7O0oGD9DFwfdOcXvC-SiJ5_XLU2AuGRNleIdazvaPgPlXUeFUF1F3_2D3scl1QOulOhbwpSilaIHyqaYcwKn5-Qnk_aaEr06rA8O6-qwXh3Wsva8fVJehgnGPx2_La0AOwC5lsIG0l-j_6v6E9_ItGw |
CitedBy_id | crossref_primary_10_3109_17453674_2015_1127726 crossref_primary_10_1038_labinvest_2017_26 crossref_primary_10_1093_jjco_hyy200 crossref_primary_10_1111_iju_13869 crossref_primary_10_1111_pin_12433 |
Cites_doi | 10.1111/j.1464-410X.2010.09688.x 10.1002/cncr.21331 10.1016/j.eururo.2006.04.009 10.1016/j.juro.2009.12.035 10.1016/j.urology.2009.02.013 10.1111/j.1464-410X.2008.08259.x 10.1111/j.1442-2042.2007.01739.x 10.1016/j.juro.2008.06.014 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R 10.1016/j.eururo.2006.12.031 10.1002/cncr.23520 10.1097/01.pas.0000249446.28713.53 10.1200/JCO.2005.07.055 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q 10.1111/j.1464-410X.2011.10667.x 10.1016/j.eururo.2007.01.106 10.1016/j.urology.2009.12.037 10.1097/00000478-200203000-00001 10.1016/j.juro.2012.04.006 10.1097/00000478-200305000-00005 10.1007/s00345-007-0210-7 10.1016/j.eururo.2008.12.026 10.1016/j.eururo.2007.12.001 |
ContentType | Journal Article |
Copyright | Japan Society of Clinical Oncology 2015 |
Copyright_xml | – notice: Japan Society of Clinical Oncology 2015 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TO 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. M0S M1P M2O MBDVC PQEST PQQKQ PQUKI PRINS Q9U 7X8 7T5 |
DOI | 10.1007/s10147-015-0840-5 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Research Library Research Library (Corporate) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic Immunology Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic MEDLINE AIDS and Cancer Research Abstracts Research Library Prep |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1437-7772 |
EndPage | 1170 |
ExternalDocumentID | 3897216171 10_1007_s10147_015_0840_5 25981949 |
Genre | Research Support, Non-U.S. Gov't Journal Article Feature |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29J 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GQ8 GRRUI GUQSH GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M2O M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z7W Z7X Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 ~EX AACDK AAEOY AAJBT AASML ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION 7TO 7XB 8FK H94 K9. MBDVC PQEST PQUKI PRINS Q9U 7X8 7T5 |
ID | FETCH-LOGICAL-c652t-3fed5cc584d7ff2f5af023f37b93837b0c45df551dbb5362a9f5147b2ad9cd423 |
IEDL.DBID | AGYKE |
ISSN | 1341-9625 |
IngestDate | Fri Aug 16 23:19:16 EDT 2024 Fri Aug 16 07:23:41 EDT 2024 Fri Sep 13 07:57:43 EDT 2024 Thu Sep 12 17:00:49 EDT 2024 Sat Sep 28 08:13:32 EDT 2024 Sat Dec 16 12:00:48 EST 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Central pathology Renal cell carcinoma Prognostic factors Cytokine Histological subtypes |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c652t-3fed5cc584d7ff2f5af023f37b93837b0c45df551dbb5362a9f5147b2ad9cd423 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://hdl.handle.net/2433/209709 |
PMID | 25981949 |
PQID | 1749602771 |
PQPubID | 43390 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1773826816 proquest_miscellaneous_1738814478 proquest_journals_1749602771 crossref_primary_10_1007_s10147_015_0840_5 pubmed_primary_25981949 springer_journals_10_1007_s10147_015_0840_5 |
PublicationCentury | 2000 |
PublicationDate | 2015-12-01 |
PublicationDateYYYYMMDD | 2015-12-01 |
PublicationDate_xml | – month: 12 year: 2015 text: 2015-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | International journal of clinical oncology |
PublicationTitleAbbrev | Int J Clin Oncol |
PublicationTitleAlternate | Int J Clin Oncol |
PublicationYear | 2015 |
Publisher | Springer Japan Springer Nature B.V |
Publisher_xml | – name: Springer Japan – name: Springer Nature B.V |
References | Eble, Sauter, Epstein (CR3) 2004 Lee, Jeon, Kwak (CR19) 2012; 110 Sobin, Gospodarowicz, Wittekind (CR4) 2010 Cheville, Lohse, Zincke (CR9) 2003; 27 Capitanio, Cloutier, Zini (CR23) 2008; 103 Leibovich, Lohse, Crispen (CR8) 2010; 183 Crispen, Tabidian, Allmer (CR25) 2010; 76 CR11 Fujii, Saito, Iimura (CR17) 2008; 180 Naito, Yamamoto, Takayama (CR18) 2010; 57 Keegan, Schupp, Chamie (CR26) 2012; 188 Cindolo, Patard, Chiodini (CR2) 2005; 104 Marumo, Kanayama, Miyao (CR1) 2007; 14 Störkel, Eble, Adlakha (CR10) 1997; 80 Delahunt, Sika-Paotonu, Bethwaite (CR12) 2007; 31 Crépel, Isbarn, Capitanio (CR24) 2009; 74 Moch, Gasser, Amin (CR7) 2000; 89 Jeon, Kwon, Rha (CR21) 2011; 107 Lam, Klatte, Patard (CR13) 2007; 52 Skolarikos, Alivizatos, Laguna (CR14) 2007; 51 Hemal, Kumar, Gupta (CR16) 2007; 25 Amin, Amin, Tamboli (CR6) 2002; 26 Patard, Leray, Rioux-Leclercq (CR22) 2005; 23 Ficarra, Martignoni, Galfano (CR5) 2006; 50 Russo, Jang, Pettus (CR15) 2008; 113 Aron, Nguyen, Stein (CR20) 2008; 54 22698625 - J Urol. 2012 Aug;188(2):391-7 17527087 - Am J Surg Pathol. 2007 Jun;31(6):957-60 19136199 - Eur Urol. 2010 Feb;57(2):317-25 11859199 - Am J Surg Pathol. 2002 Mar;26(3):281-91 18470927 - Cancer. 2008 Jul 1;113(1):84-96 10931460 - Cancer. 2000 Aug 1;89(3):604-14 16116599 - Cancer. 2005 Oct 1;104(7):1362-71 16697521 - Eur Urol. 2006 Oct;50(4):786-93; discussion 793-4 12717246 - Am J Surg Pathol. 2003 May;27(5):612-24 17593088 - Int J Urol. 2007 Jun;14(6):479-82 18707704 - J Urol. 2008 Oct;180(4):1290-5; discussion 1295-6 20171681 - J Urol. 2010 Apr;183(4):1309-15 9307203 - Cancer. 1997 Sep 1;80(5):987-9 18160207 - Eur Urol. 2008 Jul;54(1):133-40 19076149 - BJU Int. 2009 Jun;103(11):1496-500 15837991 - J Clin Oncol. 2005 Apr 20;23(12):2763-71 20223503 - Urology. 2010 Sep;76(3):580-6 17786453 - World J Urol. 2007 Dec;25(6):619-26 17316970 - Eur Urol. 2007 Jul;52(1):155-62 19628262 - Urology. 2009 Oct;74(4):842-5 17229521 - Eur Urol. 2007 Jun;51(6):1490-500; discussion 1501 21029315 - BJU Int. 2011 Mar;107(5):817-821 22085161 - BJU Int. 2012 Jul;110(2 Pt 2):E28-33 AK Hemal (840_CR16) 2007; 25 B Delahunt (840_CR12) 2007; 31 MB Amin (840_CR6) 2002; 26 P Russo (840_CR15) 2008; 113 H Moch (840_CR7) 2000; 89 M Aron (840_CR20) 2008; 54 V Ficarra (840_CR5) 2006; 50 K Marumo (840_CR1) 2007; 14 L Cindolo (840_CR2) 2005; 104 JC Cheville (840_CR9) 2003; 27 Y Fujii (840_CR17) 2008; 180 S Naito (840_CR18) 2010; 57 S Lee (840_CR19) 2012; 110 JJ Patard (840_CR22) 2005; 23 KA Keegan (840_CR26) 2012; 188 LH Sobin (840_CR4) 2010 M Crépel (840_CR24) 2009; 74 JS Lam (840_CR13) 2007; 52 840_CR11 A Skolarikos (840_CR14) 2007; 51 U Capitanio (840_CR23) 2008; 103 S Störkel (840_CR10) 1997; 80 BC Leibovich (840_CR8) 2010; 183 PL Crispen (840_CR25) 2010; 76 SH Jeon (840_CR21) 2011; 107 JN Eble (840_CR3) 2004 |
References_xml | – volume: 107 start-page: 817 year: 2011 end-page: 821 ident: CR21 article-title: Comparison of laparoscopic versus open radical nephrectomy for large renal tumors: a retrospective analysis of multi-center results publication-title: BJU Int doi: 10.1111/j.1464-410X.2010.09688.x contributor: fullname: Rha – year: 2004 ident: CR3 publication-title: Pathology and genetics. Tumors of the urinary system and male genital organs contributor: fullname: Epstein – year: 2010 ident: CR4 publication-title: TNM classification of malignant tumors contributor: fullname: Wittekind – volume: 104 start-page: 1362 year: 2005 end-page: 1371 ident: CR2 article-title: Comparison of predictive accuracy of four prognostic models for non-metastatic renal cell carcinoma after nephrectomy publication-title: Cancer doi: 10.1002/cncr.21331 contributor: fullname: Chiodini – volume: 50 start-page: 786 year: 2006 end-page: 793 ident: CR5 article-title: Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision publication-title: Eur Urol doi: 10.1016/j.eururo.2006.04.009 contributor: fullname: Galfano – volume: 183 start-page: 1309 year: 2010 end-page: 1315 ident: CR8 article-title: Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma publication-title: J Urol doi: 10.1016/j.juro.2009.12.035 contributor: fullname: Crispen – volume: 74 start-page: 842 year: 2009 end-page: 845 ident: CR24 article-title: Does histologic subtype affect oncologic outcomes after nephron-sparing surgery? publication-title: Urology doi: 10.1016/j.urology.2009.02.013 contributor: fullname: Capitanio – volume: 103 start-page: 1496 year: 2008 end-page: 1500 ident: CR23 article-title: A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study publication-title: BJU Int doi: 10.1111/j.1464-410X.2008.08259.x contributor: fullname: Zini – volume: 14 start-page: 479 year: 2007 end-page: 482 ident: CR1 article-title: prevalence of renal cell carcinoma: a nation-wide survey in Japan, 2002 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2007.01739.x contributor: fullname: Miyao – volume: 180 start-page: 1290 year: 2008 end-page: 1295 ident: CR17 article-title: External validation of the mayo clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma publication-title: J Urol doi: 10.1016/j.juro.2008.06.014 contributor: fullname: Iimura – volume: 80 start-page: 987 year: 1997 end-page: 989 ident: CR10 article-title: Classification of renal cell carcinoma: workgroup no. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC) publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R contributor: fullname: Adlakha – volume: 51 start-page: 1490 year: 2007 end-page: 1500 ident: CR14 article-title: A review on follow-up strategies for renal cell carcinoma after nephrectomy publication-title: Eur Urol doi: 10.1016/j.eururo.2006.12.031 contributor: fullname: Laguna – volume: 113 start-page: 84 year: 2008 end-page: 96 ident: CR15 article-title: Survival rates after resection for localized kidney cancer: 1989 to 2004 publication-title: Cancer doi: 10.1002/cncr.23520 contributor: fullname: Pettus – volume: 31 start-page: 957 year: 2007 end-page: 960 ident: CR12 article-title: Fuhrman grading is not appropriate for chromophobe renal cell carcinoma publication-title: Am J Surg Pathol doi: 10.1097/01.pas.0000249446.28713.53 contributor: fullname: Bethwaite – volume: 23 start-page: 2763 year: 2005 end-page: 2771 ident: CR22 article-title: Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience publication-title: J Clin Oncol doi: 10.1200/JCO.2005.07.055 contributor: fullname: Rioux-Leclercq – volume: 89 start-page: 604 year: 2000 end-page: 614 ident: CR7 article-title: Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma publication-title: Cancer doi: 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q contributor: fullname: Amin – volume: 110 start-page: E28 year: 2012 end-page: E33 ident: CR19 article-title: Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC) publication-title: BJU Int doi: 10.1111/j.1464-410X.2011.10667.x contributor: fullname: Kwak – ident: CR11 – volume: 52 start-page: 155 year: 2007 end-page: 162 ident: CR13 article-title: Prognostic relevance of tumor size in T3a renal cell carcinoma: a multicentre experience publication-title: Eur Urol doi: 10.1016/j.eururo.2007.01.106 contributor: fullname: Patard – volume: 76 start-page: 580 year: 2010 end-page: 586 ident: CR25 article-title: Unclassified renal cell carcinoma: impact on survival following nephrectomy publication-title: Urology doi: 10.1016/j.urology.2009.12.037 contributor: fullname: Allmer – volume: 26 start-page: 281 year: 2002 end-page: 291 ident: CR6 article-title: Prognostic Impact of Histologic Subtyping of Adult Renal Epithelial Neoplasms publication-title: Am J Surg Pathol doi: 10.1097/00000478-200203000-00001 contributor: fullname: Tamboli – volume: 188 start-page: 391 year: 2012 end-page: 397 ident: CR26 article-title: TM histopathology of surgically treated renal cell carcinoma survival differences by subtype and stage publication-title: J Urol doi: 10.1016/j.juro.2012.04.006 contributor: fullname: Chamie – volume: 27 start-page: 612 year: 2003 end-page: 624 ident: CR9 article-title: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma publication-title: Am J Surg Pathol doi: 10.1097/00000478-200305000-00005 contributor: fullname: Zincke – volume: 25 start-page: 619 year: 2007 end-page: 626 ident: CR16 article-title: Oncologic outcome of 132 cases of laparoscopic radical nephrectomy with intact specimen removal for T1-2N0M0 renal cell carcinoma publication-title: World J Urol doi: 10.1007/s00345-007-0210-7 contributor: fullname: Gupta – volume: 57 start-page: 317 year: 2010 end-page: 325 ident: CR18 article-title: Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients publication-title: Eur Urol doi: 10.1016/j.eururo.2008.12.026 contributor: fullname: Takayama – volume: 54 start-page: 133 year: 2008 end-page: 140 ident: CR20 article-title: Impact of gender in renal cell carcinoma: an analysis of the SEER database publication-title: Eur Urol doi: 10.1016/j.eururo.2007.12.001 contributor: fullname: Stein – volume: 183 start-page: 1309 year: 2010 ident: 840_CR8 publication-title: J Urol doi: 10.1016/j.juro.2009.12.035 contributor: fullname: BC Leibovich – volume: 57 start-page: 317 year: 2010 ident: 840_CR18 publication-title: Eur Urol doi: 10.1016/j.eururo.2008.12.026 contributor: fullname: S Naito – volume: 23 start-page: 2763 year: 2005 ident: 840_CR22 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.07.055 contributor: fullname: JJ Patard – volume: 89 start-page: 604 year: 2000 ident: 840_CR7 publication-title: Cancer doi: 10.1002/1097-0142(20000801)89:3<604::AID-CNCR16>3.0.CO;2-Q contributor: fullname: H Moch – volume: 51 start-page: 1490 year: 2007 ident: 840_CR14 publication-title: Eur Urol doi: 10.1016/j.eururo.2006.12.031 contributor: fullname: A Skolarikos – volume: 31 start-page: 957 year: 2007 ident: 840_CR12 publication-title: Am J Surg Pathol doi: 10.1097/01.pas.0000249446.28713.53 contributor: fullname: B Delahunt – volume: 14 start-page: 479 year: 2007 ident: 840_CR1 publication-title: Int J Urol doi: 10.1111/j.1442-2042.2007.01739.x contributor: fullname: K Marumo – volume: 52 start-page: 155 year: 2007 ident: 840_CR13 publication-title: Eur Urol doi: 10.1016/j.eururo.2007.01.106 contributor: fullname: JS Lam – volume: 76 start-page: 580 year: 2010 ident: 840_CR25 publication-title: Urology doi: 10.1016/j.urology.2009.12.037 contributor: fullname: PL Crispen – volume: 188 start-page: 391 year: 2012 ident: 840_CR26 publication-title: J Urol doi: 10.1016/j.juro.2012.04.006 contributor: fullname: KA Keegan – volume: 25 start-page: 619 year: 2007 ident: 840_CR16 publication-title: World J Urol doi: 10.1007/s00345-007-0210-7 contributor: fullname: AK Hemal – volume-title: Pathology and genetics. Tumors of the urinary system and male genital organs year: 2004 ident: 840_CR3 contributor: fullname: JN Eble – volume: 80 start-page: 987 year: 1997 ident: 840_CR10 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R contributor: fullname: S Störkel – volume-title: TNM classification of malignant tumors year: 2010 ident: 840_CR4 contributor: fullname: LH Sobin – ident: 840_CR11 – volume: 113 start-page: 84 year: 2008 ident: 840_CR15 publication-title: Cancer doi: 10.1002/cncr.23520 contributor: fullname: P Russo – volume: 104 start-page: 1362 year: 2005 ident: 840_CR2 publication-title: Cancer doi: 10.1002/cncr.21331 contributor: fullname: L Cindolo – volume: 103 start-page: 1496 year: 2008 ident: 840_CR23 publication-title: BJU Int doi: 10.1111/j.1464-410X.2008.08259.x contributor: fullname: U Capitanio – volume: 50 start-page: 786 year: 2006 ident: 840_CR5 publication-title: Eur Urol doi: 10.1016/j.eururo.2006.04.009 contributor: fullname: V Ficarra – volume: 74 start-page: 842 year: 2009 ident: 840_CR24 publication-title: Urology doi: 10.1016/j.urology.2009.02.013 contributor: fullname: M Crépel – volume: 26 start-page: 281 year: 2002 ident: 840_CR6 publication-title: Am J Surg Pathol doi: 10.1097/00000478-200203000-00001 contributor: fullname: MB Amin – volume: 54 start-page: 133 year: 2008 ident: 840_CR20 publication-title: Eur Urol doi: 10.1016/j.eururo.2007.12.001 contributor: fullname: M Aron – volume: 27 start-page: 612 year: 2003 ident: 840_CR9 publication-title: Am J Surg Pathol doi: 10.1097/00000478-200305000-00005 contributor: fullname: JC Cheville – volume: 107 start-page: 817 year: 2011 ident: 840_CR21 publication-title: BJU Int doi: 10.1111/j.1464-410X.2010.09688.x contributor: fullname: SH Jeon – volume: 110 start-page: E28 year: 2012 ident: 840_CR19 publication-title: BJU Int doi: 10.1111/j.1464-410X.2011.10667.x contributor: fullname: S Lee – volume: 180 start-page: 1290 year: 2008 ident: 840_CR17 publication-title: J Urol doi: 10.1016/j.juro.2008.06.014 contributor: fullname: Y Fujii |
SSID | ssj0017652 |
Score | 2.1351767 |
Snippet | Background
The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects... The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects on... Background The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects... BACKGROUNDThe purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the effects... Background: The purpose of this study was to determine the state of modern practice with regard to renal cell carcinoma (RCC) outcomes and to assess the... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1161 |
SubjectTerms | Aged Cancer Research Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - mortality Carcinoma, Renal Cell - secondary Carcinoma, Renal Cell - surgery Cytokines Cytokines - therapeutic use Disease-Free Survival Female Humans Kidney cancer Kidney Neoplasms - drug therapy Kidney Neoplasms - mortality Kidney Neoplasms - pathology Kidney Neoplasms - surgery Male Medicine Medicine & Public Health Middle Aged Neoplasm Grading Neoplasm Invasiveness Neoplasm Staging Nephrectomy Oncology Original Article Pathology Studies Surgical Oncology Survival Rate Tumor Burden |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9VAEB5qC-KLqFUbrTKCT5XlNMnuJnkqVVoOQquUFvoW9ioiTdpzch76T_y5zuRyqhT7nCWZ7Le7883ODeCjLUOM1mqhvddCxtwK4s2GAMmkKU0p075_ysmpnl_Ir5fqcgPmUy4Mh1VOZ2J_UPvW8R35jJgzke2sKNKZsXwL4LrZwfWN4P5R7Gcdm2k8gq0sleyw3fp8dPr9bO1RKHTffYfrl4mKSP_k4RzS6EgiMqoVVzndF-pfHXWPeN5zmva66PgZPB1JJB4OqD-HjdC8gMcno5t8G35_W3X0V2GJbUS3Gop7YxMYONe1V7dofpifRAxxEfhFfHuPjrsKNe2VQdZsHtsGDY6xm8iNi6djEod0F353lUrkXE1uEbBETlVBIpQYFqb_8m3X_iKBcB3N_hIujo_Ov8zF2IJBOJqvTuQxeOUcsRRfxJhFZSIp-ZgXtmLT1u47qXwk1uWtVaQLTRWJgRU2M75ynqjaK9hs2ibsAFbaO6MqG0MROCHWujzNnXQ6s9GREZrA3jTp9fVQaaO-q6nMCNWEUM0I1SqB3QmWetx0y_puiSTwYf2YtgvPomlCu-IxeVmSEVmUD42hQZkuU53A6wHytURkLRKHklUCn6Y18JcA_xP3zcPivoUnGa--PkpmFza7xSq8I67T2ffjMv4DaSL9tw priority: 102 providerName: ProQuest |
Title | Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment |
URI | https://link.springer.com/article/10.1007/s10147-015-0840-5 https://www.ncbi.nlm.nih.gov/pubmed/25981949 https://www.proquest.com/docview/1749602771/abstract/ https://search.proquest.com/docview/1738814478 https://search.proquest.com/docview/1773826816 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9RADLbarYS48H4ESjVInEBZNY-ZSY5LtaUCtSDESsspmmeFVk2q3eTQ_hJ-LnZeFC0g9ZJIyWQysT3x5_HYBnijM-e91iIU1oow9YkOETcrZEicqkxladTWTzk9EyeL9OOSL3cgHpcuytV08Ei2P-obsW74GFq-nFKRHoZ8F_Y4VaWewN7sw_dP89F3IEVbZ4cylYU5wvvBl_m3Tv7URlsQc8s92mqd4_tdJOCmTVZIm01W06bWU3O9ncrxFh_0AO71IJTNOql5CDuufAR3Tns3-2P4-bmpsRO3YZVnpumSg7PSEeNNXV1cMXWufiCwZGtHHdHqPzNUlaisLhQjzWhZVTLF-r2fjAofD79Z1oXLUN95lDKK9aQSAxtGoS4MASlza9W--aquVjggNu6GfwKL4_m3o5OwL-EQGuRCHSbeWW4MohwrvY89Vx5Bgk-kzsk01ocm5dYjarNac9SlKveI4KSOlc2NRaj3FCZlVbrnwHJhjeK59k46CqjVJokSkxoRa2_QiA3g7cDK4rLL1FH8zslMtC6Q1gXRuuAB7A_MLvpJuynQOEN7LpYyCuD1eBunG1FRla5qqE2SZWiEyux_bbBRLLJIBPCsE6RxRGhtIgZL8wDeDVJxYwD_Gu6LW7V-CXdjEqt2080-TOp1414hdKr1AezKpcRjdhQd9PMGz-_nZ1--4tVFPPsFbjgVKg |
link.rule.ids | 315,786,790,12083,12250,21416,27957,27958,31754,31755,33301,33302,33779,33780,41116,41558,42185,42627,43345,43614,43840,52146,52269,74102,74371,74659 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BVgIuFa-WlAKDxAlktUnsPE4IUKsFukuFWqm3yE-EUJOymz30n_BzmcljW1TRc6xk4s_2fON5AbwxhQ_BmExkzmVChtQI4s2aAEmkLnQh465_ymyeTU_llzN1Nly4LYewyvFM7A5q11i-I98j5kxkO8nz-P3Fb8Fdo9i7OrTQuAsbMiVTZQIbHw_mx9_XfoQ863rucNUyURLVH_2affIcyUGmtOLapvtC_auZbtDNG67STgMdPoTNgTrihx7rR3DH14_h3mxwjj-BP99WLf2LX2IT0K76kt5Ye4bLts35Jeof-ifRQVx4fhHf2aPlXkJ1c66R9ZnDpkaNQ8Qmcrvi8XDEPsmF313GEjlDkxsDLJETVJBoJPqF7r582Ta_SCBcx7A_hdPDg5NPUzE0XhCW5qsVafBOWUvcxOUhJEHpQKo9pLkp2aA1-1YqF4hrOWMUaUBdBuJduUm0K60jgrYFk7qp_TPAMnNWq9IEn3tOgzU2jVMrbZaYYMn0jODtOOnVRV9fo7qqpMwIVYRQxQhVKoLdEZZq2GrL6mphRPB6_Zg2Cc-irn2z4jFpUZDpmBe3jaFBSVbEWQTbPeRrichGJOYkywjejWvgmgD_E3fndnFfwf3pyeyoOvo8__ocHiS8Ers4mV2YtIuVf0FspzUvhyX9F0L9_Oo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Jb9UwEB5BkSouiJ1AgUHiBLLaLLaTE0KFp7K0cKBSb5FXhFCT8l7eof-En8tM4ryCKnqO5Uz8jT3fxLMAvLR1iNFaJZT3SlSxtIJ4syFAisrUpq7ysX_K4ZE6OK4-nsiTFP-0SmGV85k4HtS-d_yPfJeYM5HtQut8N6awiK_vFm_OfgnuIMU3ramdxnW4QVZR8yat9zfhHrlWY_cdrl8mGiL98w3nlEZHEpFTLbnK6Z6Q_9qoS8Tz0qXpaIsWt-FWIpH4dkL9DlwL3V3YPkzX5Pfg95f1QF8VVthHdOupuDd2gYFzQ396jua7-UHEEJeBJ-K_9-i4q1DXnxpky-ax79Bgit1Eblw8H5M4pbvw3E1eIedqcouAFXKqChKhxLA045vPh_4nCYSbaPb7cLx4_23_QKQWDMLReg2ijMFL54ileB1jEaWJZORjqW3Drq3dc5X0kViXt1aSLTRNJAambWF84zxRtQew1fVdeATYKO-MbGwMOnBCrHVlXrrKqcJGR05oBq_mRW_Ppkob7UVNZUaoJYRaRqiVGezMsLRp063aCxXJ4MXmMW0XXkXThX7NY8q6JidS11eNoUGFqnOVwcMJ8o1E5C0Sh6qaDF7POvCXAP8T9_HV4j6HbdLl9vOHo09P4GbBijgGzOzA1rBch6dEewb7bNTnP5KO_4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Outcomes+of+curative+nephrectomy+against+renal+cell+carcinoma+based+on+a+central+pathological+review+of+914+specimens+from+the+era+of+cytokine+treatment&rft.jtitle=International+journal+of+clinical+oncology&rft.au=Ito%2C+Noriyuki&rft.au=Kojima%2C+Shinsuke&rft.au=Teramukai%2C+Satoshi&rft.au=Mikami%2C+Yoshiki&rft.date=2015-12-01&rft.pub=Springer+Japan&rft.issn=1341-9625&rft.eissn=1437-7772&rft.volume=20&rft.issue=6&rft.spage=1161&rft.epage=1170&rft_id=info:doi/10.1007%2Fs10147-015-0840-5&rft.externalDocID=10_1007_s10147_015_0840_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1341-9625&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1341-9625&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1341-9625&client=summon |